Evidence map›Paper›PMID 26723900›Full record

ArticleDNA repair2016

TP53 and lacZ mutagenesis induced by 3-nitrobenzanthrone in Xpa-deficient human TP53 knock-in mouse embryo fibroblasts.

Jill E Kucab, Edwin P Zwart, Harry van Steeg, Mirjam Luijten, Heinz H Schmeiser, David H Phillips, Volker M Arlt

Open access · hybridAbstract read
In one paragraph

Article in DNA repair, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Nutlin-3a selects for cells harbouring TP53 mutations.International journal of cancer · 2017
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Jill E KucabAnalytical and Environmental Sciences Division, MRC-PHE Centre for Environment & Health, King's College London, London SE1 9NH, United Kingdom. Electronic address: jill.kucab@kcl.ac.uk.
Edwin P ZwartCenter for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven 3721 MA, The Netherlands.
Harry van SteegCenter for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven 3721 MA, The Netherlands.
Mirjam LuijtenCenter for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven 3721 MA, The Netherlands.
Heinz H SchmeiserDivision of Radiopharmaceutical Chemistry (E030), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
David H PhillipsAnalytical and Environmental Sciences Division, MRC-PHE Centre for Environment & Health, King's College London, London SE1 9NH, United Kingdom.
Volker M ArltAnalytical and Environmental Sciences Division, MRC-PHE Centre for Environment & Health, King's College London, London SE1 9NH, United Kingdom.
King's College London · GBNational Institute for Public Health and the Environment · NLGerman Cancer Research Center · DE

Funding

Cancer Research UK 14329Cancer Research UK C313/A14329Wellcome Trust 101126Wellcome Trust 101126/B/13/ZWellcome Trust 101126/Z/13/Z
6 · The paper itself

Abstract

3-Nitrobenzanthrone (3-NBA) is a highly mutagenic compound and possible human carcinogen found in diesel exhaust. 3-NBA forms bulky DNA adducts following metabolic activation and induces predominantly G:CT:A transversions in a variety of experimental systems. Here we investigated the influence of nucleotide excision repair (NER) on 3-NBA-induced mutagenesis of the human tumour suppressor gene TP53 and the reporter gene lacZ. To this end we utilised Xpa -knockout (Xpa-Null) human TP53 knock-in (Hupki) embryo fibroblasts (HUFs). As Xpa is essential for NER of bulky DNA adducts, we hypothesized that DNA adducts induced by 3-NBA would persist in the genomes of Xpa-Null cells and lead to an increased frequency of mutation. The HUF immortalisation assay was used to select for cells harbouring TP53 mutations following mutagen exposure. We found that Xpa-Null Hupki mice and HUFs were more sensitive to 3-NBA treatment than their wild-type (Xpa-WT) counterparts. However, following 3-NBA treatment and immortalisation, a similar frequency of TP53-mutant clones arose from Xpa-WT and Xpa-Null HUF cultures. In cells from both Xpa genotypes G:CT:A transversion was the predominant TP53 mutation type and mutations exhibited bias towards the non-transcribed strand. Thirty-two percent of 3-NBA-induced TP53 mutations occurred at CpG sites, all of which are hotspots for mutation in smokers' lung cancer (codons 157, 158, 175, 245, 248, 273, 282). We also examined 3-NBA-induced mutagenesis of an integrated lacZ reporter gene in HUFs, where we again observed a similar mutant frequency in Xpa-WT and Xpa-Null cells. Our findings suggest that 3-NBA-DNA adducts may evade removal by global genomic NER; the persistence of 3-NBA adducts in DNA may be an important factor in its mutagenicity.

Indexed as

DNA RepairMutagenesisAnimalsBenz(a)AnthracenesDNADNA AdductsDNA DamageFemaleFibroblastsGene DeletionGenes, BacterialLac OperonMiceMice, Mutant StrainsMutagensTumor Suppressor Protein p533-nitrobenzanthroneBenz(a)AnthracenesDNADNA AdductsMutagensTP53 protein, humanTumor Suppressor Protein p53Xeroderma Pigmentosum Group A ProteinXpa protein, mouse3-NitrobenzanthroneDNA adductEnvironmental carcinogenMutationNucleotide excision repairTP53

Identifiers

PMID26723900
PMCPMC4798848
OpenAlexW2192746675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.